Consensus Guidelines for Managing Inflammatory Bowel Disease in Low- and Middle-Income Nations

Overview

Inflammatory bowel disease (IBD) incidence and prevalence are rising in low- and middle-income countries (LMICs), presenting unique diagnostic and treatment challenges due to limited resources and healthcare infrastructure. The European Crohn’s and Colitis Organisation (ECCO) developed consensus guidelines to address these issues, emphasizing the need for improved awareness, early diagnosis, multidisciplinary care, and tailored management strategies in LMICs.

Background

IBD, including Crohn’s disease and ulcerative colitis, has traditionally been more prevalent in high-income countries but is increasingly diagnosed in LMICs due to urbanization and lifestyle changes. Accurate epidemiological data remain scarce in these regions, complicated by misdiagnosis and infectious diseases mimicking IBD. Treatment challenges include limited access to advanced therapies and surgical care, often resulting in emergency surgeries with higher complication rates. ECCO convened experts from LMICs to develop consensus guidelines reflecting these unique challenges and resource constraints.

Data Highlights

Key Findings

• IBD incidence and prevalence are increasing in LMICs, though reliable epidemiological data are limited (Evidence Level 3).
• Diagnostic challenges in LMICs include frequent misdiagnosis due to infectious diseases like gastrointestinal tuberculosis and amoebiasis mimicking IBD.
• Resource limitations restrict access to early diagnostic modalities, advanced medical therapies, and specialist multidisciplinary care.
• Surgical intervention is often required due to delayed diagnosis and advanced disease, with many surgeries performed emergently, increasing postoperative complications and mortality.
• Existing IBD guidelines from high-income countries may not be fully applicable in LMIC settings due to differences in healthcare infrastructure and resource availability.
• There is a critical need for further research to assess LMIC-specific needs to guide resource allocation and improve IBD management.

Clinical Implications

Healthcare professionals managing IBD in LMICs should prioritize increasing awareness and early diagnosis to reduce emergency surgical interventions. Tailored treatment approaches considering resource constraints are essential, including strengthening multidisciplinary teams and improving access to appropriate therapies. Policymakers should support research and infrastructure development to address the unique challenges of IBD care in these settings.

Conclusion

The rising burden of IBD in LMICs necessitates context-specific management guidelines that address diagnostic and therapeutic challenges unique to resource-limited environments. ECCO’s consensus provides a foundation for improving care and highlights the urgent need for further research and healthcare system strengthening in these regions.

References

1. ECCO Consensus Guidelines 2024 -- Consensus Guidelines for Managing Inflammatory Bowel Disease in Low- and Middle-Income Nations